Drug harms in the UK: a multicriteria decision analysis.

By David J. Nutt, L. King, L. Phillips. The Lancet, 2010

1,459 citations recorded by the source corpus.

Subfields: Epidemiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/06e908830b573a13a3e13001b00d766dc66391f5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Alejandra Duenas
2. P. Thokala
3. Marcus Munafò
4. Oliver D. Howes

In Public Health, Environmental and Occupational Health

1. Alejandra Duenas
2. P. Thokala
3. Robin L. Carhart-Harris
4. R. Morriss
5. David J. Nutt
6. Marcus Munafò

Citations in the corpus

• Multiple criteria decision analysis for health technology assessment. (2012, methodology): “MCDA has also been used to inform health care decisions [30– 32], setting priorities for HTAs [33], and other governmental issues [34,35].”
• Serotonin and brain function: a tale of two receptors (2017, background): “, 2014 – see Carhart-Harris and Goodwin, 2017 for a review) – and about their harm, comparative rating scales suggest 5-HT2AR agonist psychedelics like psilocybin are among the least harmful drugs of potential misuse (Carhart-Harris and Nutt, 2013; Nutt et al., 2010; van Amsterdam et al., 2015).”
• Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology (2009, positive): “It is an approach that has also informed the estimate of relative harms by drugs that are used ‘recreationally’ (Nutt et al., 2010).”